BackXBiotech Overview

XBiotech Current Assets

Track XBiotech's current assets ($120M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$117.05M
↓ 25.77% YoYΔ $-40.64M vs prior year quarter

Peer average / median

Loading

XBiotech Current Assets History

Loading

XBiotech vs. peers: Current Assets Comparison

Loading

XBiotech Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

XBiotech (XBIT) FAQ

XBiotech (XBIT) currently reports a current assets of $120M as of March 2026. That compares with $160M in the prior-year period — down 25.8% year over year. Use the charts on this page to explore XBiotech's current assets history and peer comparisons.

XBiotech's current assets decreased from $160M to $120M — a 25.8% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

XBiotech reported $120M in current assets as of March 2026. That compares with $160M in the prior-year period — down 25.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $120M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for XBiotech, and consider following XBIT for alerts when major investors trade the stock.

XBiotech is classified in the Healthcare sector. On current assets, it currently shows $120M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing XBIT with unrelated industries.